Life Sciences BC News, August 22, 2024 | |
Tomorrow is the last day to purchase tickets to join us for our Annual LSBC Awards Gala! As one of our most prestigious events of the year, it’s not to be missed. Celebrate and connect with leaders and trailblazers who have helped to build our exciting, dynamic, and uniquely collaborative ecosystem—this is the last chance to buy your tickets here. | |
This year, we are recognizing Chinook Therapeutics as the 2024 Deal of the Year. It looks like the team took little time to rest on the success of the Novartis acquisition and is already diving into their next venture. | |
Photo source: The Globe and Mail | |
|
Excerpt from Globe & Mail article by Sean Silcoff, “San Francisco-based Versant Ventures and Swiss pharma giant Novartis AG are set to announce Thursday that they have committed US$150-million to launch Borealis Biosciences, a startup that will develop RNA medicines to fight kidney disease. The vast majority of Borealis’s 25-person founding team previously worked for Chinook Therapeutics Inc., which was hatched in Vancouver by Versant and bought last year by Novartis for US$3.5-billion. Borealis will operate out of the same Vancouver office and labs previously occupied by Chinook […]
“In many ways, Borealis is Chinook 2.0,” said Versant’s Vancouver-based managing director, Jerel Davis, who is also the new company’s executive chair.” Read the full article here.
| |
WELL Health continues the momentum in the digital health space with its majority-owned subsidiary, Wisp, the leading sexual and reproductive telehealth provider in the United States. Wisp has reached one million patients in the US and has recorded more than C$100 million in run rate revenue. This milestone firmly establishes Wisp as the largest and fastest-growing telehealth platform for women, offering innovative and first-to-market products throughout every stage of a woman’s health journey. Read more. | |
|
Tell us about your lab space needs: LSBC pulse survey
LSBC will be undertaking a short pulse survey by phone this August to gather important information on our sector’s lab space needs. Data will be anonymized and aggregated and available to the sector, including government, for planning purposes.
Help support this important data collection through participating in our very short phone survey if contacted. Or please reach out to us at Labspace@lifesciencesbc.ca
| |
|
The School of Biomedical Engineering (SBME) announces $5 million from Pacifican to help launch the new Biodevice Foundry at SBME—a state-of-the-art facility for designing, prototyping, fabricating and testing biodevices that will help accelerate biomedical innovation and grow the life sciences industry to transform health locally and globally. Read more.
NanoVation Therapeutics publishes its first chemistry paper in the Journal of Organic Chemistry. Congratulations to the team. Read more.
Johnson & Johnson acquires V-Wave Ltd., a privately-held company focused on developing innovative treatment options for patients with heart failure for an upfront payment of $600 million, with the potential for additional regulatory and commercial milestone payments up to approximately $1.1 billion. V-Wave will join Johnson & Johnson as part of Johnson & Johnson MedTech. Read more.
Novartis celebrates the Canada-wide Implementation of newborn screening for Spinal Muscular Atrophy (SMA). With these programs in place, a blood test routinely done shortly after birth will be able to detect SMA before symptoms appear. Novartis is pleased to have contributed to this shift in policy across the country through a multi-year multi-phase collaboration with Muscular Dystrophy Canada. Read more.
| |
|
University of British Columbia receives over $8.8 million to drive innovation in life sciences and food processing. UBC is receiving $5 million to establish the Biodevice Foundry to provide growing companies with lab space, specialized equipment and training programs to develop and test their products. UBC is also receiving over $3.8 million to establish a world-class Food and Beverage Innovation Centre. Read more.
Canada’s Minister of Health announced an investment of more than $7.6 million through the Immunization Partnership Fund (IPF) for 31 projects over the next two years. These projects will use innovative approaches to increase vaccine uptake and confidence in communities facing barriers to vaccination. Read more.
| |
Total Flow Medical is a Vancouver-based medical device company on a mission to improve the quality of care for heart surgery and life support patients. Learn more. | |
|
LifeLabs, a partner of the BC Centre for Disease Control’s GetCheckedOnline program, announced that the program was recognized as the 2024 Global Winner of the UNIVANTS of Healthcare Excellence Award. LifeLabs plays an integral role in delivering GetCheckedOnline through collection services at select centres. Read more.
Congratulations to Molecular You, who were selected to pitch at the 2024 CharmHealth Innovation Challenge. Molecular You will be showcasing their revolutionary healthcare solutions at the Innovation Exhibit. Read more.
| |
HTuO Biosciences announced that Neil Klompas has been appointed to their board of directors. Neil is currently the President and CEO of Augurex Life Sciences and a board member at NervGen Pharma. Read more. | |
|
The Trade Accelerator Program (TAP) is a 5-day program offering essential strategy, resources and mentorship, equipping small and medium-sized businesses to scale up, develop and activate an export plan. The Greater Vancouver Board of Trade is offering a full bursary to LSBC members - which covers the full program cost of $5,000. When applying online, companies can simply mention Life Sciences BC as their referral contact to receive the bursary. Learn more.
Innovation, Science and Economic Development Canada has opened a consultation on the growing usage of AI. Researchers or businesses that use AI are invited to share their thoughts on how the Government of Canada can expand existing computing infrastructure. Share your thoughts by September 6, 2024. Learn more.
The Canadian Institutes of Health Research announced a new funding opportunity for researchers! Over $16 million in grants is available to fund research teams studying neurodegeneration in aging. Register your team by November 6, 2024! Learn more.
The Trade Commissioner Service in Miami and San Francisco have partnered with the Mayo Clinic Innovation Exchange to offer an opportunity to participate in a virtual program from October 2024 to March 2025. Connect with healthcare entrepreneurs, start-ups, and sector leaders at this business accelerator opportunity. The application period ends September 4, 2024 (ET). Learn more.
Registration is open for The School of Biomedical Engineering's micro-certificate in Innovation Leadership: Medical and Bio-Innovations. This is a part-time blended program that addresses the gap between scientific and technological innovations and the practical, legal, and strategic skills needed to bring these innovations to market successfully. Join an information session on September 25 to learn more.
|  | See our expanded list of current life sciences opportunities on our website. | |
|
Jevitty Life Science Corp is a Vancouver BC based company, with the mission of developing and delivering technologies for human longevity and healthspan.
The Bodycomp division of Jevitty (www.bodycomp.ca) provides dexa body composition scans at multiple locations in the Lower Mainland, as well as NeuroCatch brain health diagnostic scans.
Jevitty invests in and participates with various companies that are working on leading edge projects to further the objectives of living healthy and happy well beyond the current age expectancy.
Jevitty also has an interactive app that provides users with a useful dashboard for ongoing healthy activities, products and services, on both the IOS and Android platforms. Learn more.
| |
|
Until next week!
LSBC Team
| |
|
September 10 - Join us on September 10, 2024, as we celebrate excellence in life sciences at the 26th Annual Life Sciences BC Awards, presented by Farris.
This distinguished occasion brings together British Columbia’s vibrant life sciences community to celebrate the outstanding achievements of our peers and recognize the tireless efforts of those who have devoted their careers to advancing health innovations.
| |
|
October 29 & 30 - Life Sciences BC is pleased to announce the 9th annual Invest in BC presented by Lumira Ventures conference.
This highly anticipated event serves as a premier gathering for healthcare innovators in British Columbia, connecting them with global investors. This year we’ve reimagined the conference, offering attendees a dynamic two-day program featuring 30+ company pitches from pre-seed to public.
| | |
|
|
Augurex to Present Research on Novel Diagnostic 14-3-3η Auto-Antibody Marker for Axial Spondyloarthritis at the Spondylo Congress in Ghent
Augurex Life Sciences announced that it will be presenting a scientific poster at the upcoming Spondylo Congress, taking place in Ghent, Belgium, from September 5th to 7th, 2024...Read more.
| | |
|
|
InMed Pharmaceuticals Strengthens Patent Portfolio with Issuance of Three U.S. Patents
InMed was issued three U.S. patents: one for its formulation and method of use in the treatment of epidermolysis bullosa and related connective tissue disorders, one for biosynthesis manufacturing processes and one for an ocular drug delivery formulation...Read more.
| | |
|
|
InMed Pharmaceuticals Demonstrates INM-901 as an Oral Formulation Targeting Alzheimer’s Disease
InMed Pharmaceuticals, a pharmaceutical company developing a pipeline of drug candidates for diseases with high unmet medical needs, confirms INM-901 as an oral formulation that will be utilized in its development programs for Alzheimer’s disease...Read more.
| | |
|
|
WEX Pharmaceuticals Inc. Files US Patent Application for Use of Tetrodotoxin in Ocular Applications
WEX Pharmaceuticals, a clinical-stage biotechnology company developing Halneuron® for pain, is pleased to announce the filing of a U.S. patent application for the use of Tetrodotoxin for ocular applications…Read more.
| | |
|
|
Novartis Celebrates Canada-wide Implementation of Newborn Screening for Spinal Muscular Atrophy
Novartis Pharmaceuticals Canada Inc. applauds the work done by Muscular Dystrophy Canada and the provinces to ensure that every newborn in Canada will be screened to detect spinal muscular atrophy…Read more.
| | |
|
|
SBME Awarded $5 Million from PacifiCan for a New Biodevice Foundry
Together, government and philanthropic support has helped to launch the new Biodevice Foundry at SBME—a state-of-the-art facility for designing, prototyping, fabricating and testing biodevices that will help accelerate biomedical innovation and grow the life sciences industry...Read more.
| | |
|
|
Positive Results from Lexaria’s Molecular Characterization Study
Lexaria Bioscience announces positive findings from its applied research program together with the National Research Council of Canada that evaluated important mode of action facets of DehydraTECH processed with the glucagon-peptide 1 drug, semaglutide...Read more.
| | |
|
|
European Commission Grants Second Indication Approval for TEPKINLY® for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
AbbVie announced that the European Commission has granted conditional marketing authorization for TEPKINLY® as a monotherapy for the treatment of adult patients with relapsed or refractory follicular lymphoma after two or more lines of prior therapy…Read more.
| | |
|
|
LifeLabs and British Columbia Centre for Disease Control Celebrate Global Recognition for GetCheckedOnline Program
LifeLabs, a proud partner of the British Columbia Centre for Disease Control’s GetCheckedOnline program, is thrilled to announce that the program has been recognized as the 2024 Global Winner of the prestigious UNIVANTS of Healthcare Excellence Award…Read more.
| | |
|
|
CASTL and STERIS Announce Applied Cleaning Validation Master Class
The Canadian Alliance for Skills and Training in Life Sciences is pleased to partner with STERIS, a leading provider of infection prevention and other procedural products and services, to offer a master class course in Applied Cleaning Validation this fall in Charlottetown, PEI...Read more.
| | |
|
|
Senior Administrator, Human Resources
The Senior Administrator will be responsible for coordinating recruitment scheduling for executive level positions (VP and above), scheduling Senior Hire orientations and supporting training events for department heads...Learn more
| | |
|
|
Team Lead, Clinical Genotyping
Reporting to the Assistant Laboratory Director, the Team Lead, Clinical Genotyping coordinates and provides work direction to the Clinical Laboratory Drug Resistance Testing and Genotyping team...Learn more
| | |
|
|
Research and Innovation Manager, Health
The Research and Innovation Manager, Health is a collaborative member of the Research and Innovation team and works seamlessly across the organization...Learn more
| | |
|
|
HR Coordinator/Senior HR Coordinator
The Human Resources Coordinator/Sr. Human Resources Coordinator is responsible for ensuring the entering and coordination of data, documents and processes into the various HR systems in an accurate and timely manner to ensure flawless execution...Learn more
| | |
|
|
Manager, Capital Campaign
St. Paul’s Foundation is seeking a Manager, Capital Campaign to be an integral part of an established, respected non-profit on the cusp of opening an incredible new hospital, research complex, and health campus...Learn more
| | |
|
|
Senior Scientist, CMC, Drug Product
The candidate will be responsible for leading the development of suitable formulations for the in vivo assessment (including for GLP toxicology studies) of novel chemical compounds originating from our Discovery team...Learn more
| | |
|
|
Laboratory Assistant, Lab & Facilities
The Lab Operations Assistant will be responsible for a variety of tasks, including consumables inventory management, restocking lab supplies, shipping/receiving and maintaining equipment in good working order...Learn more
| | |
|
|
Senior Animal Care Technician (18 month contract)
The Sr. Animal Care Technician reports to the Director, In Vivo Resources and is responsible for the various technical procedures that support the scientific research conducted during the execution of in vivo studies...Learn more
| | |
|
|
Principal Scientist – Discovery Protein Sciences
The Therapeutic Discovery organization is seeking to fill a position at the Principal Scientist level in our Discovery Protein Sciences group in Vancouver, Canada. This position, which is laboratory-based, will support the design and generation of complex biological molecules...Learn more
| | |
|
|
Senior Associate, LNP Internal Manufacturing
As the Sr. Associate, Internal LNP Manufacturing, you will have a key role manufacturing, testing and shipping LNP drug products for multiple partner programs as part of this crucial department...Learn more
| | |
|
|
Senior Manager, CMC, Quality Control
The Senior Manager, CMC, Quality Control will work flexibly across several small molecule drug development programs with an emphasis on managing outsourced testing and stability program for the cGMP API and drug product manufacturing and testing campaigns...Learn more
| | |
|
|
Clinical Scientist 1 or 2
The Clinical Scientist 1 or 2 will be a member of a highly collaborative Clinical Development team, with involvement in a diverse range of activities. This position reports to the Vice President, Clinical Development...Learn more
| | |
|
Post a Job on the LSBC Website | |
LSBC Membership Discounts on Job Postings
As an LSBC member, your first five job postings EARN a free repost on BioTalent Canada's The Petri Dish. After your first five posts, you will also receive 25 per cent off all job postings on The Petri Dish. Want more info? Contact talent@lifesciencesbc.ca.
| |
Total Flow Medical is a Vancouver-based medical device company on a mission to improve the quality of care for heart surgery and life support patients.
Total Flow Medical’s first product is a cannula for cardiopulmonary bypass. Our products are designed by clinicians, easy-to-use, integrate within existing clinical workflow and help surgeons take care of their patients’ limbs and lives. Learn more.
|
|
If you haven't already, sign-up for this and our weekly events newsletter | |
Follow LSBC on Social Media | | | | |
